SOURCE: DC Brands International, Inc.

September 19, 2007 14:08 ET

Turn Left Energy Drink Reviewed on

DENVER, CO--(Marketwire - September 19, 2007) - Turn Left, the racing-themed energy drink from DC Brands International (PINKSHEETS: DCBI), has just been reviewed on An internationally-recognized resource for the beverage industry, provides continually updated information and product reviews. In fact, visitors can add comments and post their own reviews to the site.

Turn Left received a favorable assessment from the editor: "[Turn Left] features a light berry flavor that is crisp and sweet, with a mild bite of energy to the finish. The graphics on the can are certainly in line with a racing-themed product, complete with race cars and checkered flags...Overall, a good tasting drink with a unique theme."

DC Brands is adding additional information to the review, including logo, contact information and images.

About DC Brands International:

DC Brands International, a publicly traded company under the ticker symbol (PINKSHEETS: DCBI), specializes in and manufactures unique energy drink brands. Established in 1998, DC Brands went public in 2005, and the company's first product, Dickens Energy Cider, launched in 2002 after a lengthy process in developing its distinctive flavor and packaging. Following the success of Dickens Energy Cider, the company chose to expand its product line with a beverage that filled the substantial NASCAR niche. With more than 75 million loyal fans, the NASCAR demographic presented an attractive opportunity to become one of the few racecar-themed energy drinks in the marketplace. Following much due diligence, research and testing, Turn Left Energy Drink recently came to fruition.

For more information on DC Brands International, visit their website at and

Note: Except for the historical information contained herein, this news release contains forward-looking statements that involve substantial risks and uncertainties. Among the factors that could cause actual results or timelines to differ materially are risks associated with research and clinical development, regulatory approvals, supply capabilities and reliance on third-party manufacturers, product commercialization, competition, litigation, and the other risk factors listed from time to time in reports filed by DC Brands International with the Securities and Exchange Commission, including but not limited to risks described under the caption "Important Factors That May Affect Our Business, Our Results of Operation and Our Stock Price." The forward-looking statements contained in this news release represent judgments of the management of DC Brands International as of the date of this release. DC Brands International and its managers and agents undertake no obligation to publicly update any forward-looking statements.

Contact Information